Availability of Assays for Definitive Diagnosis of Primary Hyperoxaluria Types 1 and 2
To the Editor:
We read with interest the paper by Dietzen et al. [1] on improving the extraction and therefore the quantification of urinary glycerate and glycolate. Since this paper went to press, there have been further developments in the field of primary hyperoxaluria (PH) that may be of interest to your readers. Dietzen et al. correctly state that normal glycolate excretion does not exclude PH1. However, we now know that increased glycolate excretion cannot always confirm a diagnosis of this disease ( [2] and personal observations), so measurement of urinary metabolites cannot be conclusive. In addition, although l-glycerate is a marker of PH2, most methods cannot distinguish between the d and l isomers and, because of the small numbers studied, we do not yet know whether excretion of the l-isomer is unequivocally increased in all cases of PH2.
There is therefore a requirement for definitive diagnosis of these diseases by measurement of enzyme activity-not only because of the implications for treatment (hepatic vs renal transplantation) but also for counseling of families with respect to risk of recurrence. Methods are now available for the measurement of the relevant enzymes for PH1 and PH2 in a single needle liver biopsy [3, 4] . 
